Literature DB >> 21471753

Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer.

Andrew P Stillwell1, Petra G Buettner, Simon K Siu, Russell W Stitz, Andrew R L Stevenson, Yik-Hong Ho.   

Abstract

BACKGROUND: Limited information is available on predictors of postoperative mortality, morbidity, and long-term survival in patients with stage IV colorectal cancer.
OBJECTIVE: This study aimed to identify independent predictors of postoperative mortality and morbidity as well as independent predictors of long-term survival.
DESIGN: This study was planned as a retrospective single-institution review.
SETTING: This study took place at the Department of Surgery, The Royal Brisbane and Women's Hospital, Australia, between 1984 and 2004. PARTICIPANTS: Prospectively collected data were extracted from the records of 1867 patients undergoing treatment for colorectal cancer. The outcomes for 379 patients undergoing surgical resection of their primary colon or rectal tumor in the presence of unresectable synchronous metastases were analyzed. MAIN OUTCOME MEASURES: Independent predictive factors for postoperative mortality and morbidity as well as long-term survival were assessed by use of logistic regression and Cox regression analysis.
RESULTS: Thirty-five (9.2%) patients died in the postoperative period and morbidity was 48.3%. Median survival was 11 months. Thirty-day postoperative mortality was independently associated with medical complications (P < .001), emergency operations (P = .001), female sex (P = .002), and age (≥ 70; P = .007) on regression analysis. Elderly (≥ 70) patients with either advanced local disease or extrahepatic metastases were at a particularly high risk. Preoperative predictors of surgical morbidity included male sex (P = .028) and advanced local disease (P = .036). Preoperative predictors of medical complications included repeat operations (P < .001), elevated urea levels (P = .017), and emergency operations (P = .003). Independent factors associated with poor overall survival included medical complications (P < .001), nodal stage (N2) (P = .004), poor tumor differentiation (P = .006), and apical lymph node involvement (P = .042). A subgroup of patients with advanced nodal disease (N2) and a poor tumor differentiation had a significantly poorer prognosis. LIMITATIONS: This study was limited by its retrospective nature.
CONCLUSION: Elderly patients with advanced local disease or extrahepatic metastases are at high risk of 30-day postoperative mortality. Significant nodal disease and poor tumor differentiation are important predictors of long-term survival.

Entities:  

Mesh:

Year:  2011        PMID: 21471753     DOI: 10.1007/DCR.0b013e3182083d9d

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  19 in total

1.  Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database.

Authors:  Hirotoshi Kobayashi; Hiroaki Miyata; Mitsukazu Gotoh; Hideo Baba; Wataru Kimura; Yuko Kitagawa; Tohru Nakagoe; Mitsuo Shimada; Naohiro Tomita; Kenichi Sugihara; Masaki Mori
Journal:  J Gastroenterol       Date:  2013-07-27       Impact factor: 7.527

2.  Laparoscopic surgery for rectal cancer: preoperative radiochemotherapy versus surgery alone.

Authors:  Quentin Denost; Christophe Laurent; Thomas Paumet; Laurence Quintane; Mathieu Martenot; Eric Rullier
Journal:  Surg Endosc       Date:  2012-01-05       Impact factor: 4.584

3.  Role of a liver-first approach for synchronous colorectal liver metastases.

Authors:  Kun Wang; Wei Liu; Xiao-Luan Yan; Bao-Cai Xing
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 4.  The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma.

Authors:  A A P Slesser; A Bhangu; G Brown; S Mudan; P P Tekkis
Journal:  Tech Coloproctol       Date:  2012-09-26       Impact factor: 3.781

5.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

Review 6.  Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

Authors:  Louis de Mestier; Gilles Manceau; Cindy Neuzillet; Jean Baptiste Bachet; Jean Philippe Spano; Reza Kianmanesh; Jean Christophe Vaillant; Olivier Bouché; Laurent Hannoun; Mehdi Karoui
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

7.  Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis.

Authors:  Seon Jeong Jeong; Yong Sik Yoon; Jung Bok Lee; Jong Lyul Lee; Chan Wook Kim; In Ja Park; Seok Byung Lim; Chang Sik Yu; Jin Cheon Kim
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

Review 8.  A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases.

Authors:  Vincent W T Lam; Jerome M Laurence; Tony Pang; Emma Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson
Journal:  HPB (Oxford)       Date:  2013-03-19       Impact factor: 3.647

9.  Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

Authors:  Laurence E McCahill; Greg Yothers; Saima Sharif; Nicholas J Petrelli; Lily Lau Lai; Naftali Bechar; Jeffrey K Giguere; Shaker R Dakhil; Louis Fehrenbacher; Samia H Lopa; Lawrence D Wagman; Michael J O'Connell; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  Laparoscopy is not enough: full ERAS compliance is the key to improvement of short-term outcomes after colectomy for cancer.

Authors:  Hélène Meillat; Clément Brun; Christophe Zemmour; Cécile de Chaisemartin; Olivier Turrini; Marion Faucher; Bernard Lelong
Journal:  Surg Endosc       Date:  2019-08-05       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.